Beranda › Asma › Texas

Uji klinis Asma di Texas

20 studi untuk Asma mencari peserta di lokasi di Texas.

Kota di Texas

Teks studi resmi (Bahasa Inggris)

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

GSK Investigational Site, Dallas
GSK Investigational Site, Kerrville

Menerima pesertaFase 3

Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05757102

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

GSK Investigational Site, Cypress
GSK Investigational Site, Tomball

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07645248

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Research Site, Austin
Research Site, Boerne
Research Site, Dallas
dan 6 lainnya

Menerima pesertaFase 2

Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06932263

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

Enveda Investigative Site, McKinney

Menerima pesertaFase 2

Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07301255

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

Research Site 17, San Antonio
Research Site 07, Sugar Land

Menerima pesertaFase 3

Usia 12 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07359846

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
Horizon Clinical Research Group, Cypress
Alina Clinical Trials, LLC., Dallas
dan 2 lainnya

Menerima pesertaFase 2

Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06977581

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

Research Site 24, Amarillo
Research Site 19, Baytown
Research Site 07, Dallas
dan 6 lainnya

Menerima pesertaFase 3

Usia 12 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07276724

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Research Site, Dallas
Research Site, Houston
Research Site, San Antonio

Menerima pesertaFase 3

Usia 5 hingga 11 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06023589

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Teva Investigational Site 12083, Austin
Teva Investigational Site 12060, Austin
Teva Investigational Site 12179, Cypress
dan 13 lainnya

Menerima pesertaFase 3

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT06664619

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

Research Site, Lewisville
Research Site, San Antonio

Menerima pesertaFase 2

Usia 4 hingga 11 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07525375

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

GSK Investigational Site, San Antonio

Menerima pesertaFase 3

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07456033

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Research Site, Austin
Research Site, Baytown
Research Site, Beaumont
dan 12 lainnya

Menerima pesertaFase 3

Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT06307665

A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283

GSK Investigational Site, Austin

Menerima pesertaFase 1Sukarelawan sehat diterima

Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT07712393

A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma

Research site, Dallas
Research site, Houston
Research site, San Antonio

Menerima pesertaFase 2

Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07532265

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

Orion Clinical Research, Austin
Pharmaceutical Research & Consulting, Inc., Dallas
Western Sky Medical Research, El Paso

Menerima pesertaStudi observasional

Usia 5 hingga 100 · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT07228026

Escitalopram in Asthma Patients With Frequent Exacerbation

UT Southwestern, 1440 Empire Central, Ste. LD4.100, Dallas

Menerima pesertaFase 2

Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 26 Jan 2026 · NCT06216535

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

Baylor College of Medicine, Houston

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jan 2026 · NCT06273072

Individualizing Treatment for Asthma in Primary Care (Full Study)

JPS Health Network, Fort Worth
Kelsey Research Foundation, Houston

Menerima pesertaFase 4

Usia 13 hingga 75 · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT07052942

Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study

University of Texas at Arlington, Arlington
Rebuilding Together North Texas, Plano

Menerima peserta

Usia 5 ke atas · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT07196436

Viral Mucosal Reprogramming

University of Texas Medical Branch, Galveston

Menerima pesertaFase 2Sukarelawan sehat diterima

Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 28 Jan 2025 · NCT05331170

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.